Clostridium difficile (C. diff)

Biotech

FDA committee votes for Ferring's C. difficile therapy

Ferring Pharmaceuticals’ biotherapeutic passed an FDA committee vote for C. difficile despite some skepticism from a handful of members.
James Waldron Sep 23, 2022 10:15am

Summit will take scenic route up FDA mountain

Jul 14, 2022 11:29am

Equipped with new safety data, Seres eyes FDA approval

Jun 7, 2022 7:00am

Finch's C. diff drug cleared of FDA hold, but work remains

Apr 29, 2022 8:42am

Finch's nest thins out: 20% of employees cut in restructuring

Apr 19, 2022 10:44am

Summit turns to partnerships for failed C. difficile med

Mar 18, 2022 11:18am